BIOS Capital Management
Latest statistics and disclosures from BIOS Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACTU, IRD, CGTX, RNTX, LTRN, and represent 99.53% of BIOS Capital Management's stock portfolio.
- Added to shares of these 1 stock: RNTX.
- Reduced shares in these 2 stocks: LTRN, INAB.
- BIOS Capital Management was a net buyer of stock by $54k.
- BIOS Capital Management has $53M in assets under management (AUM), dropping by -36.01%.
- Central Index Key (CIK): 0001813845
Tip: Access up to 7 years of quarterly data
Positions held by BIOS Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 52.1 | $28M | 10M | 2.74 |
|
|
| Ocuphire Pharma (IRD) | 31.7 | $17M | 3.7M | 4.55 |
|
|
| Cognition Therapeutics (CGTX) | 8.6 | $4.6M | 6.0M | 0.76 |
|
|
| Rein Therapeutics Com New (RNTX) | 4.9 | $2.6M | +17% | 2.0M | 1.30 |
|
| Lantern Pharma (LTRN) | 2.2 | $1.2M | -14% | 864k | 1.37 |
|
| In8bio Com New (INAB) | 0.5 | $248k | -33% | 168k | 1.48 |
|
Past Filings by BIOS Capital Management
SEC 13F filings are viewable for BIOS Capital Management going back to 2024
- BIOS Capital Management 2026 Q1 filed May 13, 2026
- BIOS Capital Management 2025 Q4 filed Feb. 13, 2026
- BIOS Capital Management 2025 Q3 filed Nov. 12, 2025
- BIOS Capital Management 2025 Q2 filed Aug. 12, 2025
- BIOS Capital Management 2025 Q1 filed May 14, 2025
- BIOS Capital Management 2024 Q4 restated filed Feb. 18, 2025
- BIOS Capital Management 2024 Q4 filed Feb. 10, 2025